The english version of the website is under development. Wherever text appears in Greek, it means it has not been translated yet.

Publications

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 78 results:
Author Title Type [ Year(Asc)]
Filters: Keyword is Non-alcoholic Fatty Liver Disease  [Clear All Filters]
2017
Polyzos, S. A., Kountouras J., & Mantzoros C. S. (2017).  Adipose tissue, obesity and non-alcoholic fatty liver disease.. Minerva Endocrinol. 42(2), 92-108.
Lazaridis, N., & Tsochatzis E. (2017).  Current and future treatment options in non-alcoholic steatohepatitis (NASH).. Expert Rev Gastroenterol Hepatol. 11(4), 357-369.
Polyzos, S. A., Kountouras J., Mantzoros C. S., Polymerou V., & Katsinelos P. (2017).  Effects of combined low-dose spironolactone plus vitamin E vs vitamin E monotherapy on insulin resistance, non-invasive indices of steatosis and fibrosis, and adipokine levels in non-alcoholic fatty liver disease: a randomized controlled trial.. Diabetes Obes Metab. 19(12), 1805-1809.
Polyzos, S. A. (2017).  Endocrine and metabolic disorders interplaying with non-alcoholic fatty liver disease.. Minerva Endocrinol. 42(2), 89-91.
Mintziori, G., Poulakos P., Tsametis C., & Goulis D. G. (2017).  Hypogonadism and non-alcoholic fatty liver disease.. Minerva Endocrinol. 42(2), 145-150.
Kountouras, J., Polyzos S. A., Katsinelos P., Doulberis M., Zavos C., Kazakos E., et al. (2017).  Letter: Helicobacter pylori in lean and obese patients with non-alcoholic fatty liver disease.. Aliment Pharmacol Ther. 46(6), 637-638.
Kountouras, J., Polyzos S. A., Kapetanakis N., Katsinelos P., Nikolopoulos P., Stogianni A., et al. (2017).  Letter: Helicobacter pylori-related non-alcoholic fatty liver disease with concomitant metabolic syndrome as risk factor for colorectal neoplasia.. Aliment Pharmacol Ther. 45(4), 576-577.
Polyzos, S. A., Bugianesi E., Kountouras J., & Mantzoros C. S. (2017).  Nonalcoholic fatty liver disease: Updates on associations with the metabolic syndrome and lipid profile and effects of treatment with PPAR-γ agonists.. Metabolism. 66, 64-68.
Makri, E., & Tziomalos K. (2017).  Prevalence, etiology and management of non-alcoholic fatty liver disease in patients with polycystic ovary syndrome.. Minerva Endocrinol. 42(2), 122-131.

Pages

Contact

Secretariat of the School of Medicine
 

Connect

School of Medicine's presence in social networks
Follow Us or Connect with us.